Navigation Links
Yongye Biotechnology International Raises $ 9.0 Million In Private Placement, Raises Guidance
Date:5/8/2009

and drive expansion of the distribution network. We can now measure the successful results of this strategy through the increased number of orders we received. The funds from this new private placement will help us fill the orders we received for our upcoming busy season, the second and third quarters of the year," said Mr. Zishen Wu, CEO of Yongye Biotechnology International, Inc.

The securities issued in the private placement are not registered under the United States Securities Act of 1933 or the securities laws of any other jurisdiction. Accordingly, these securities may not be sold by investors in the United States, except pursuant to an effective registration statement or an applicable exemption from the registration requirements. For more detailed information on this financing, see the Company's Current Report on Form 8-K which will be filed with the Securities and Exchange Commission on or about May 8, 2009.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Yongye Biotechnology International, Inc.

Yongye Biotechnology International, Inc., headquartered in Beijing, is engaged in the development and distribution of fulvic acid based nutrients for plants and animals. The Company's patent pending processes and proprietary formulas allow it to create products which increase crop yields and improve the health of livestock. Its sole operating subsidiary, Yongye Nongfeng Biotechnology Company, Ltd., is located in Inner Mongolia. The Company sells its products through distributors and directly to farmers located in ten provinces throughout China.

Forward Looking Statements

Certain statements set forth in this press release constitute "Forward- looking statement
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Yongye Biotechnology Distributor has Record Breaking Single Store Sales Day
2. Yongye Biotechnology Announces Preliminary Results for its Fiscal Quarter Ended March 31, 2009
3. Yongye Biotechnology Appoints New Chief Financial Officer
4. Yongye Biotechnology Announces Preliminary Results for Fiscal Year 2008
5. Yongye Biotechnology to Host Virtual Retail Road Show to Provide Overview of the Company in English and Mandarin
6. Yongye Biotechnology International to Expand its Network of Branded Stores
7. Yongye Biotechnology to Present at Roth Conference
8. Yongye Biotechnology Announces Record Third Quarter Results
9. Yongye Biotechnology to Present at Roth Capital China Comes to Vegas Conference
10. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
11. Yongye Biotechnology International Raises $9.4 Million in Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015 Seahorse Bioscience, ... metabolism, is the provider of XF Technology which ... disease research areas. As the links between mitochondrial ... cell metabolism is escalating rapidly.   ... the Nature Publishing Group (NPG) featuring XF Technology, ...
(Date:7/28/2015)... , July 28, 2015 Deerfield Management ... Healthcare Innovations Fund, L.P., which will invest in groundbreaking ... in genetic diseases, cancer, and orphan diseases. The venture ... transform how therapeutics are developed and improve the way ... one of the largest healthcare-focused venture funds in the ...
(Date:7/28/2015)... July 28, 2015 CSL Behring ... has accepted for review the company,s Biologics License Application ... (rVIII-SingleChain) for the treatment of hemophilia A. In the ... Hemophilia A is a congenital ... nearly all affected patients are male. People with hemophilia ...
(Date:7/27/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... on Thursday, July 30, 2015, after the close of ... by a conference call with the investment community at ... will be Robert A. Bradway , chairman and ... management team. Live audio of the conference ...
Breaking Biology Technology:XF Technology Used to Demonstrate Feasibility of Stem Cell Regenerative Technique 2XF Technology Used to Demonstrate Feasibility of Stem Cell Regenerative Technique 3Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3Amgen Announces Webcast of 2015 Second Quarter Financial Results 2
... - Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG), an ... March 31, 2010 . , , ... Quarter Ended March 31, 2010 , ... Company recorded $49.06 million of revenues for the quarter ended March ...
... 17 Sigma-Aldrich Corporation (Nasdaq: SIAL ) will be presenting at ... 1:15 PM CDT ( 2:15 PM EDT ) in Chicago, ... available at http://investor.sigmaaldrich.com/ .  Users can click the "Webcast" icon to access ... About ...
... , ... Company’s Certification Covers Advanced Mixed-Signal ASIC Design Services and CMOS Imaging Chips , ... Pasadena, California (PRWEB) May ... was certified to ISO 9001:2008 standards , by the registrar PJR. Forza is ...
Cached Biology Technology:Dragon Pharma reports 2010 first quarter financial results 2Dragon Pharma reports 2010 first quarter financial results 3Dragon Pharma reports 2010 first quarter financial results 4Dragon Pharma reports 2010 first quarter financial results 5Sigma-Aldrich Corporation to Present at the Baird's 2010 Growth Stock Conference on Thursday, May 20, 2010 2Forza Silicon Achieves ISO 9001 Certification 2
(Date:7/21/2015)... 21, 2015  NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market ... that it has filed provisional patent 62/192218 for ... This invention highlights next generation payment ... account, but also the user using unique personal ...
(Date:7/13/2015)... Calif. , July 13, 2015 ... developer of human interface solutions, today announced sampling ... touch and display driver integration (TDDI) product targeting ... the first to combine Synaptics , best-in-class ... proven display driver technology developed in the company,s ...
(Date:7/9/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/98rrmr/biometrics_for ... "Biometrics for Banking; Market & Technology Analysis, Adoption ... offering. The adoption for banking purposes ... the forecast is that by 2020 it will ... in delivering biometric systems to the banking industry. ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... Speak at Advanced Identification ... Systems/Commercial Biometrics Conference, SAN ... leader in secure biometric co-processor solutions, announced today,that ... will,present "Secure Biometric Co-processor: Solving the Network Security,Puzzle" ...
... an increasingly used X-ray-based tool for providing a three-dimensional view ... scanning to diagnose injury, cancer and other health problems is ... some cases unnecessarily" What are the health consequences of having ... life" In a Nov. 29, 2007 article in The ...
... malaria parasite has been studied for decades, but surprisingly, ... to cause disease. In a groundbreaking study published November ... international research team has for the first time measured ... off during actual infection in humans, not in cell ...
Cached Biology News:Atmel's Biometric Co-processor Solution Featured at AIS/CBX 2Columbia researchers: Growth of CT scan use may lead to significant public health problem 2Columbia researchers: Growth of CT scan use may lead to significant public health problem 3Study of malaria parasite in patient blood finds distinct physiological states 2Study of malaria parasite in patient blood finds distinct physiological states 3Study of malaria parasite in patient blood finds distinct physiological states 4
... This exceptionally sensitive nucleic acid gel stain has ... background in gels, making it ideal for detecting ... UV transilluminators. SYBR Green I nucleic acid ... electrophoresis, real-time PCR assays and bandshift assays. ...
... 1) Persistent Analysis Environment 2) Dot ... etc. 3) Software Compensation 4) Cell ... Kinetics Platform 7) Intelligent batch generation of ... smoothing 9) Single drag-and-drop operations to perform ...
Synonym: modified Grace's Insect medium...
Eagle's Ham's amino acids; EHAA...
Biology Products: